NACB diabetes guidelines
This article was originally published in The Gray Sheet
Executive Summary
Glycated hemoglobin should be measured at least biannually in diabetic patients to document glycemic control, according to National Academy of Clinical Biochemistry (NACB) guidelines to be published in the March issue of Clinical Chemistry. Entitled "Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus," the guidelines were released in draft form in 2000 (1"The Gray Sheet" Aug. 7, 2000, p. 14). Authored by NACB with input from the American Diabetes Association, and approved by the ADA professional practice committee, the guidelines' recommendations also include annual microalbumin testing for pubertal or postpubertal diabetics without clinical proteinuria starting five years after diagnosis of type 1 and at the time of type 2 diagnosis. The document also recommends an annual lipid profile for diabetic adults...
You may also be interested in...
NACB Diabetes Guidelines Cautious On Less-Invasive Glucose Monitoring
"Routine" minimally invasive glucose sensing with Cygnus' GlucoWatch Biographer and MiniMed's CGMS continuous glucose monitor system is not recommended by the National Academy of Clinical Biochemistry (NACB) in a recent draft of the group's diabetes management guidelines.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.